Investigation of a new molecular target-based treatment of caneer-drug resistant pediatric solid tumors
Investigation of a new molecular target-based treatment of caneer-drug resistant pediatric solid tumors
批准号:
15591098
负责人:
KAMIJO Takehiko
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
神经母细胞瘤(NB)是最常见的儿童来自交感神经系统的实体恶性肿瘤。与许多儿童恶性肿瘤的生存率提高不同,高风险成空细胞瘤仍然是最难治愈的肿瘤之一,尽管进行了强化多模式治疗,但长期生存率仅为30%。为了提高生存率,需要新的治疗方法和更好地了解耐药机制。神经母细胞瘤研究的一个值得注意的发现是,在340个测试的NBs中,据报道p53肿瘤抑制基因突变不到2% (Tweddle DA et al., Cancer Res 61: 8-13, 2001)。p53的细胞质隔离已被认为是NB细胞失活的另一种机制,而不是突变。这种分离首先是用免疫组织化学技术在冷冻肿瘤样本中报道的(Moll UM et al., PNAS 92: 4407- 11,1995),后来用免疫荧光和细胞分离实验在NB油系中报道的……More s (Moll UM et al., MCB 16: 1126- 37,1996)。然而,DNA损伤刺激前后p53的定位、p53的磷酸化稳定和激活、体外和体内与p53结合共识序列的结合、p53下游分子在NB细胞中的上调等仍有待研究。因此,我们通过一组细胞系来确定NB细胞中p53依赖性细胞死亡是否由细胞凋亡功能引起,并进一步研究p53依赖性途径诱导细胞凋亡的分子机制。我们提供了一系列证据,证明p53依赖的应激,多柔比星(Doxo)给药,导致p53在NB细胞细胞核中积累,并在多柔比星敏感和耐药的NB细胞系中磷酸化几个丝氨酸残基(丝氨酸15、丝氨酸20和丝氨酸46)。仅在doxo敏感的NB细胞中观察到p53下游分子p2lCip 1/Waf1的上调和线粒体中促凋亡的Bcl-2家族分子Noxa的积累。在敏感细胞中引起线粒体功能障碍,包括细胞色素c释放和膜电位失调,导致内在caspase途径激活。然而,在耐p53的NB细胞中,细胞核内的积累和p53的磷酸化并不能诱导Noxa的积累和线粒体功能障碍。令人惊讶的是,过度表达MDM2导致p53失活,从而取消线粒体中Noxa的上调,减少凋亡细胞的死亡。综上所述,MDM2/p53通路似乎通过线粒体中的Noxa调控在NB细胞中发挥重要作用。少
英文摘要
Neuroblastoma (NB) is the most common pediatric solid malignant tumor derived from the sympathetic nervous system. Unlike the improvements in survival in many childhood malignancies, high-risk neumblastoma is still one of the most difficult tumors to cure, with only 30% long-term survival despite intensive multi-modal therapy. New treatments and a better understanding of drug resistance mechanisms are required for improvement of the survival rates. A noteworthy finding of neuroblastoma research is that mutations of p53 tumor suppressor have been reported less than 2% of NBs out of 340 tested (Tweddle DA et al., Cancer Res 61 : 8-13, 2001). Instead of mutation, cytoplasmic sequestration of p53 has been proposed as an alternative mechanism of inactivation in NB cells. The sequestration was first reported in frozen tumor samples using immuno-histodremical techniques (Moll UM et al., PNAS 92 : 4407-11, 1995) and later in NB oil lines by immuno-fluorescence and cell fractionation experiment … More s (Moll UM et al., MCB 16 : 1126-37, 1996). However, the p53 localization before and after DNA damage stimulation, p53 stabilization and activation by phosphorylation, binding to the p53-binding consensus sequences in vitro and in vivo, and up-regulation of p53-dowmstream molecules in NB cells have remained to be determined.Therefore, we employed a panel of cell lines to determine whether the p53-dependent cell death in NB cells is caused by apoptotic cellular function, and we further studied the molecular mechanism of apoptosis induced via p53-dependent pathway. We provide lines of evidence that a p53-dependent stress, doxorubicin (Doxo) administration, causes accumulation of p53 in nucleus of NB cells and phosphorylation of several serine residues (serine 15, serine 20, and serine 46) in both Doxo-sensitive and -resistant NB cell lines. Up-regulation of a p53-downstream molecule, p2lCip 1/Waf1 and accumulation of Noxa, a pro-apoptotic Bcl-2 family molecule, in mitochondria are observed in only Doxo-sensitive NB cells. Mitochondrial dysfunction including cytochrome c release and membrane potential dysregulation was caused in the sensitive cells, resulting in the activation of the intrinsic caspase pathway. However, the accumulation in nucleus and phosphorylation of p53 were inert to induce the Noxa accumulation and the mitochondrial dysfunction in p53-resistant NB cells. Surprisingly, inactivation of the p53 by over-expression of MDM2 resulted in the canceling of up-regulation of Noxa in mitochondria and reduced the apoptotic cell death. Taken together, MDM2/p53 pathway seems to play an important role in NB cells by Noxa regulation in mitochondria. Less
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
ST1571 inhibits growth and adhesion of human mast cells in culture.
ST1571 抑制培养物中人类肥大细胞的生长和粘附。
DOI:
--
发表时间:
2003
期刊:
J Leukoc Biol. 74
影响因子:
--
作者:
[Takeuchi K, Koike K, Kamijo T, 他10名]
通讯作者:
他10名
DOI:
10.1074/jbc.m300510200
发表时间:
2003-07
期刊:
Journal of Biological Chemistry
影响因子:
4.8
作者:
[Y. Nakazawa;T. Kamijo;K. Koike;T. Noda]
通讯作者:
Y. Nakazawa;T. Kamijo;K. Koike;T. Noda
STI571 inhibits growth and adhesion of human mast cells in culture
STI571 抑制培养物中人类肥大细胞的生长和粘附
DOI:
10.1189/jlb.0602284
发表时间:
2003
期刊:
Journal of Leukocyte Biology
影响因子:
5.5
作者:
[K. Takeuchi, K. Koike, T. Kamijo, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Sakashita, T. Kinoshita, Shigeyuki Matsuzawa, M. Shiohara, T. Yamashita, M. Nakajima, A. Komiyama]
通讯作者:
A. Komiyama
Tanaka M, Kamijo T et al.: "Specific Autoantibodies to Platelet Glycoproteins in Epstein-Barr Virus-Associated Immune Thrombocytopenia"Int J Hematol. 78. 168-170 (2003)
Tanaka M、Kamijo T 等人:“Epstein-Barr 病毒相关免疫性血小板减少症中血小板糖蛋白的特异性自身抗体”Int J Hematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6-month-old infant with congenital neutropenia complicated by severe pneumonia.
对一名患有先天性中性粒细胞减少症并发严重肺炎的 6 个月大婴儿,使用降低强度调理方案成功进行无关脐带血移植。
DOI:
--
发表时间:
2004
期刊:
Int J Hematol. 80(3)
影响因子:
--
作者:
[Nakazawa Y, Sakashita K, Kinoshita M, Saida K, Shigemura T, Yanagisawa R, Shikama N, Kamijo T, Koike K.]
通讯作者:
Koike K.
共 14 条
Development of cancer stem cell-targeted therapy by study of tumor sphere formation mechanism using comprehensive and genetic approach
-
批准号:24390269
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:KAMIJO Takehiko
-
依托单位:
Screening of polycomb Bmi1 targets for development of Cancer Stem Cell-targeted therapy for neuroblastoma
-
批准号:21591377
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:KAMIJO Takehiko
-
依托单位:
Investigation of new molecular target of neuroblastoma therapy: The role of p53 pathway in neuroblastoma cell death
-
批准号:17591077
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2005
-
负责人:KAMIJO Takehiko
-
依托单位:
Analysis of Molecular Mechanism of ARF-dependent apoptotic cell death
-
批准号:13214040
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$21.76万
-
财政年份:2001
-
负责人:KAMIJO Takehiko
-
依托单位:
Analysis of the mechanism for suppression of childhood leukemia via ARF-p53 pathway
-
批准号:12670736
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:KAMIJO Takehiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
H3K27me3–MEG3–MDM2/p53轴在髓母细胞瘤凋亡逃逸中作用机制的研究
-
批准号:2026JJ81839
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:符星
-
依托单位:
假尿苷修饰介导tRNA-Glu剪切产生 tRF-30-87R8WP9N1EWJ调控肝癌中MDM2/p53通路的机制研究
-
批准号:JCZRYB202500445
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
AKAP5竞争性结合MDM2蛋白以正向调控突变型p53在三阴性乳腺癌免疫逃逸中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:盛贤能
-
依托单位:
FEEF1A1通过MDM2调控p53在急性B淋巴细胞白血病中的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:吴集青
-
依托单位:
新型多肽类似物Tn3a靶向Mdm2/MdmX恢复p53抑癌活性的机制研究
-
批准号:32301020
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:成细瑶
-
依托单位:
淫羊藿苷调控MDM2/P53/SLC7A11轴促进结肠癌细胞铁死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
环状RNA circHIST1H1D调控的MDM2/p53信号通路在胶质瘤干细胞恶性表型中的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:蒋炀
-
依托单位:
白花地胆草单体EM12靶向MDM2/p53负反馈环抗肿瘤作用及其分子机制
-
批准号:82074064
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:李强
-
依托单位:
靶向MDM2/p53信号通路小分子抑制剂APG-115通过促进胃癌细胞自噬介导T细胞免疫激活的机制研究
-
批准号:82003268
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:张琳
-
依托单位:
HO-1核转位调控NPM1/MDM2/p53/Arf:非酶活性依赖的血管内皮应激性衰老调节新机制
-
批准号:81973318
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:李卓明
-
依托单位: